Acupuncture and Moxibustion for Parkinson's (NCT06874803)
Reduce early Parkinsons motor symptoms
- Trial ID
- NCT06874803
- Official Title
- Effect of "Qi-Tonifying, Yang-Warming, and Water-Resolving" Acupuncture and Moxibustion for Motor Symptom Improvement in Early Parkinson's Disease (WARMED): A Randomized Controlled Trial
- Goal
- Reduce early Parkinsons motor symptoms
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Jiani Wu
- Study Type
- INTERVENTIONAL
- Enrollment
- 60 participants
- Conditions
- Parkinson's Disease (PD)
- Interventions
- Acupuncture and Moxibustion (AM), Sham Acupuncture and Moxibustion (Sham-AM)
Summary For Families
It tests whether a traditional acupuncture plus moxibustion protocol that aims to "tonify qi, warm yang, and resolve water" can improve motor symptoms in people with early, mild-to-moderate Parkinson's. The treatment uses needles at specific points together with localized heat from burning mugwort to stimulate nerves and tissues, and investigators think that sensory stimulation may alter brain and spinal cord signaling, muscle control, or local inflammation; they compare real treatment to a sham procedure to see if effects are specific. Because it is non-drug, it would be used alongside usual Parkinson medications like levodopa rather than replacing them. Enrollment is for people aged 30 to 80 with PD by the 2016 Chinese criteria and Hoehn-Yahr stage under 3, excluding Parkinson-plus syndromes, prior DBS, severe medical or psychiatric conditions, bleeding disorders, recent acupuncture, pregnancy, or recent trial participation.
Locations
- Guang'anmen Hospita, China Academy of Chinese Medical Sciences, Beijing, Beijing Municipality, China
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Acupuncture and Moxibustion (AM). It tests whether a traditional acupuncture plus moxibustion protocol that aims to "tonify qi, warm yang, and resolve water" can improve motor symptoms in people with early, mild-to-moderate Parkinson's. The treatment uses needles at specific points together with localized heat from burning mugwort to stimulate nerves and tissues, and investigators think that sensory stimulation may alter brain and spinal cord signaling, muscle control, or local inflammation; they compare real treatment to a sham procedure to see if effects are specific. Because it is non-drug, it would be used alongside usual Parkinson medications like levodopa rather than replacing them. Enrollment is for people aged 30 to 80 with PD by the 2016 Chinese criteria and Hoehn-Yahr stage under 3, excluding Parkinson-plus syndromes, prior DBS, severe medical or psychiatric conditions, bleeding disorders, recent acupuncture, pregnancy, or recent trial participation.
- Who can participate?
- Participants must be between 30 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 1 month.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This trial has 2 groups, and 1 is a sham (a pretend version of the procedure) group. Because assignment is random, you have about a 1 in 2 chance (roughly 50%) of being in the sham group, assuming the groups are filled equally. Ask the coordinator to confirm the exact assignment ratio.
- How many visits does this trial involve?
- Participants will have 24 treatment sessions over eight weeks, three times per week.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: MRI scan (non-invasive). Confirm the full schedule with the study coordinator.